Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Endocrine Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01936467
What this trial is testing

Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions

Who this might be right for
Pancreatic Solid LesionsPancreatic Mass
Johns Hopkins University 121
Testing effectiveness (Phase 2)WithdrawnNCT06592664
What this trial is testing

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Who this might be right for
Pancreas CancerPancreatic CarcinomaPancreas Adenocarcinoma+5 more
Lisata Therapeutics, Inc.
Early research (Phase 1)Ended earlyNCT01086332
What this trial is testing

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University of Iowa 7
Not applicableStudy completedNCT06888401
What this trial is testing

Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal

Who this might be right for
CholangiocarcinomaBile Duct CarcinomaEndoscopic Retrograde Cholangio-Pancreatography+1 more
Kathmandu University School of Medical Sciences 597
Very early researchWithdrawnNCT04870034
What this trial is testing

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

Who this might be right for
Colorectal CarcinomaLung AdenocarcinomaMalignant Solid Neoplasm+1 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00410774
What this trial is testing

Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery

Who this might be right for
Pancreatic Cancer
University of California, San Francisco 20
Early research (Phase 1)Study completedNCT00338026
What this trial is testing

A Phase I Study of ECO-4601 in Patients With Advanced Cancer

Who this might be right for
TumorsGliomaColorectal Cancer+5 more
Thallion Pharmaceuticals 26
Not applicableStudy completedNCT05876273
What this trial is testing

Neural-net Artificial Pancreas (NAP)

Who this might be right for
Type1 Diabetes
University of Virginia 15
Large-scale testing (Phase 3)UnknownNCT00486460
What this trial is testing

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tel-Aviv Sourasky Medical Center
Early research (Phase 1)Study completedNCT01352962
What this trial is testing

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00652054
What this trial is testing

Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Taiho Oncology, Inc. 39
Testing effectiveness (Phase 2)Study completedNCT02511223
What this trial is testing

Efficacy and Safety of PARPi to Treat Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sheba Medical Center 24
Not applicableEnded earlyNCT01387659
What this trial is testing

Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations

Who this might be right for
DiabetesImmunosuppression
The University of Texas Medical Branch, Galveston 2
Testing effectiveness (Phase 2)Study completedNCT00004910
What this trial is testing

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more
Northwestern University
Not applicableStudy completedNCT03267524
What this trial is testing

Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers

Who this might be right for
Adult Liver CarcinomaCaregiverColorectal Carcinoma+3 more
City of Hope Medical Center 87
Not applicableUnknownNCT03679169
What this trial is testing

Evaluation of Complete microscopicE Resection Margin (R0) and Lymph Node Involvement After Standard Pancreatosplenectomy (SPS) Versus Radical Anterograde Modular Pancreatosplenectomy

Who this might be right for
Pancreatic Cancer
Institut Paoli-Calmettes 260
Not applicableStudy completedNCT07651020
What this trial is testing

The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

Who this might be right for
Pancreatic CancerBreast CancerLung Cancer+6 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1
Testing effectiveness (Phase 2)Study completedNCT00769483
What this trial is testing

MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
M.D. Anderson Cancer Center 81
Early research (Phase 1)Ended earlyNCT01946646
What this trial is testing

Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
National Taiwan University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00922896
What this trial is testing

Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Gyeongsang National University Hospital 22
Next Page